Michigan’s system of bail and pretrial release is ripe for reform, but any changes to this complex structure require a thorough understanding of current practices and how they diverge from best practices. Analysts at the Mackinac Center and the ACLU of Michigan both published papers to inform the public about bail in our state, which they will present jointly.

Ajit Pai is the Chairman of the Federal Communications Commission, but his philosophy is a bit different than many regulators. Pai’s regulatory philosophy values consumers, competition and markets over regulation, bureaucrats and central planning. His principles include being aware of “regulatory capture,” a free and fair system without dispensing favors and special treatment, flexible rulemaking, and rules which respect the laws of Congress.

Join the Mackinac Center for a private screening of the compelling film about small town heroes who challenged one of the nation’s largest pharmaceutical corporations and an overreaching government all the way to the Supreme Court.

Featuring: Jason Hayes, director of environmental policy at the Mackinac Center for Public Policy.

This panel will discuss issues related to the future of internet networks, including 5G cell service, “net neutrality” and broadband infrastructure. Panelists will also offer guidance on what governments at all levels — local, state and federal — should do (or not do) in relation to the future of internet connectivity and the spinoff technologies it makes possible.

The Mackinac Center for Public Policy announces our 2018 Planning for Life Workshops around Michigan.

The Mackinac Center for Public Policy announces our 2018 Planning for Life Workshops around Michigan.

Michigan’s rules about alcohol production, distribution and sales are complex. The state has restrictions on what can be produced, a strict monopoly system for distribution and imposes price controls on sellers. Many of these regulations were originally crafted some 80 years ago in the post-Prohibition era.

In recent years the price consumers pay for many brand name prescription drugs and even some generics has increased. There are several factors behind these increases. One has to do with the type of the drugs being developed today and the smaller number of patients they target. Another involves middlemen that absorb many of the price discounts provided by drug makers. And a third has to do with the regulations coming from both Washington and the states.

Join us for an evening of fellowship among friends of liberty.